Clinical Trial Update: Safety and Efficacy of DA-9805 for Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial results for DA-9805 in Parkinson's disease have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• DA-9805

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-05-24